In the weeds: a baseline view of cannabis use among legalizing states and their neighbours

被引:106
作者
Pacula, Rosalie Liccardo [1 ]
Jacobson, Mireille [2 ]
Maksabedian, Ervant J. [3 ]
机构
[1] RAND Corp, Drug Policy Res Ctr, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA
[2] Univ Calif Irvine, Sch Business, Irvine, CA USA
[3] RAND Corp, Pardee RAND Grad Sch, Santa Monica, CA 90407 USA
关键词
Cannabis legalization; medical cannabis; recreational cannabis; mode of use; MEDICINAL USE; MARIJUANA USE; CONCURRENT; PATTERNS; PAIN;
D O I
10.1111/add.13282
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To describe patterns of cannabis use, the degree of overlap between medicinal and recreational users, and their differential use patterns, modes of consumption and sources of cannabis. Design An ongoing probability-based internet panel maintained by the market research firm GfK Group. Setting Households in Colorado, Washington, Oregon and New Mexico, USA. Participants A total of 2009 individuals from Washington (n = 787), Oregon (n = 506), Colorado (n = 503) and New Mexico (n = 213). Post stratification sampling weights were provided so that estimates could be made representative of the household population in each of these states. Respondents were aged between 18 and 91 years, with a mean age of 53 years. Methods We compare patterns of cannabis consumption for medicinal and recreational users as well as simultaneous use of alcohol and cannabis. We also examine the extent to which patterns of use differ across states that chose to legalize (Washington and Colorado) and those that did not (New Mexico and Oregon). Findings Rates of life-time medical cannabis use are similar in Colorado and Washington (8.8% and 8.2%) but lower in Oregon and New Mexico (6.5% and 1%). Recreational use is considerably higher than medical use across all states (41%), but highest in Oregon and Washington. Approximately 86% of people who report ever using cannabis for medicinal purposes also use it recreationally. Medical users are more likely to vaporize and consume edibles and report a higher amount (in grams) consumed, and spend more money per month than recreational users. Individuals who use cannabis do not commonly use it with alcohol, irrespective of whether they are consuming cannabis recreationally or medically. Fewer than one in five recreational users report simultaneous use of alcohol and cannabis most or all of the time and fewer than 3% of medicinal users report frequent simultaneous use of alcohol and cannabis. Conclusions In the United States, the degree of overlap between medicinal and recreational cannabis users is 86%. Medicinal and recreational cannabis users favor different modes and amounts of consumption. Only a small proportion (12%) of cannabis users usually consume cannabis and alcohol simultaneously, while concurrent use is common among recreational users.
引用
收藏
页码:973 / 980
页数:8
相关论文
共 21 条
[1]   Patterns of cannabis use among patients with multiple sclerosis [J].
Clark, AJ ;
Ware, MA ;
Yazer, E ;
Murray, TJ ;
Lynch, ME .
NEUROLOGY, 2004, 62 (11) :2098-2100
[2]   Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum [J].
Cohen, Peter J. .
JOURNAL OF LAW MEDICINE & ETHICS, 2010, 38 (03) :654-666
[3]  
Colorado Department of Public Health and Environment Health and Environmental Informations and Statistics Division, 2016, MED US MAR
[4]   Examining the debate on the use of medical marijuana [J].
DuPont, RL .
PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (02) :166-172
[5]   Concurrent versus simultaneous polydrug use: Prevalence, correlates, discriminant validity, and prospective effects on health outcomes [J].
Earleywine, M ;
Newcomb, MD .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1997, 5 (04) :353-364
[6]   Medicinal and recreational marijuana use by patients infected with HIV [J].
Furler, MD ;
Einarson, TR ;
Millson, M ;
Walmsley, S ;
Bendayan, R .
AIDS PATIENT CARE AND STDS, 2004, 18 (04) :215-228
[7]   The Medicinal Use of Cannabis and Cannabinoids-An International Cross-Sectional Survey on Administration Forms [J].
Hazekamp, Arno ;
Ware, Mark A. ;
Muller-Vahl, Kirsten R. ;
Abrams, Donald ;
Grotenhermen, Franjo .
JOURNAL OF PSYCHOACTIVE DRUGS, 2013, 45 (03) :199-210
[8]   Physicians and Medical Marijuana [J].
Kleber, Herbert D. ;
DuPont, Robert L. .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (06) :564-568
[9]  
Malanick C. E., 1996, DATA PRIORITIES POPU
[10]  
Nunberg Helen, 2011, J Drug Policy Anal, V4